Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
23
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
20
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Innoviz Technologies
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Autonomous And Smart Cities Will Accelerate LiDAR Adoption
Key Takeaways Rapid acceleration in bookings, strong OEM partnerships, and entry into diverse sectors position Innoviz for superior growth, recurring revenues, and market leadership in LiDAR. Scale advantages, high-value nonautomotive markets, and cost-lowering innovations are expected to significantly boost margins and speed up positive net earnings.
View narrative
US$4.00
FV
59.0% undervalued
intrinsic discount
134.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Synthomer
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Urban Expansion And Eco Policies Will Spur Specialty Chemicals
Key Takeaways Specialization in higher-margin products, site reduction, and broader divestments accelerate deleveraging, capital efficiency, and stronger cash flow growth. Global expansion and industry partnerships position Synthomer for superior revenue, margin growth, and reduced geographic risk amid rising sustainable material demand.
View narrative
UK£3.48
FV
81.7% undervalued
intrinsic discount
6.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Canopy Growth
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Global Cannabis Legalization Will Unlock Medical And Wellness Markets
Key Takeaways Regulatory reforms and global legalization trends are unlocking major new markets, supporting aggressive expansion and elevating Canopy's market share and margin potential. Innovation in high-value products and improved capital access are enabling Canopy to dominate premium segments, fueling higher long-term profitability and growth.
View narrative
CA$8.00
FV
79.0% undervalued
intrinsic discount
7.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Restaurant Brands Asia
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Digital Rollout And Expansion Will Capture Urban Demand In Asia
Key Takeaways Aggressive digital, AI, and expansion strategies are driving operational efficiency, customer loyalty, and set up for significant gains in sales and profitability. Rapid café innovation, targeted marketing, and supply chain optimization position the company for substantial revenue growth and margin expansion in a rising market.
View narrative
₹125.07
FV
35.9% undervalued
intrinsic discount
18.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Hudson Pacific Properties
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Digital Content Surge And Urban Migration Will Elevate Premium Leasing
Key Takeaways Accelerated leasing from tech and AI tenants, along with studio demand growth, could drive rapid recovery in occupancy, revenue, and studio cash flows. Cost reductions and a focus on sustainable, amenity-rich assets uniquely positions the company for margin expansion, premium rents, and outsized asset valuation gains.
View narrative
US$4.97
FV
47.7% undervalued
intrinsic discount
6.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Aquestive Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Patient Centric Needle-Free Therapies Will Capture Global Markets
Key Takeaways Accelerated global expansion and unique patient-first strategies could drive faster uptake and broader revenue diversification for Anaphylm than analysts currently anticipate. Oral film technology and scalable PharmFilm portfolio position the company for sustained leadership, margin expansion, and strong long-term earnings leverage as care models evolve.
View narrative
US$14.30
FV
72.9% undervalued
intrinsic discount
59.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Pacific Biosciences of California
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Vega Shipments And Multi-Omics Trends Will Fuel Genomics Breakthroughs
Key Takeaways Accelerated adoption of new platforms and technologies is expanding PacBio's user base, international reach, and revenue diversification opportunities. Advances in product offerings and strategic partnerships are enhancing margins, market positioning, and access to high-growth clinical and precision medicine segments.
View narrative
US$3.00
FV
57.7% undervalued
intrinsic discount
21.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 12 hours ago
author updated this narrative
Arteris
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
AI And Automotive Trends Will Drive Advanced Chip Adoption
Key Takeaways Landmark customer wins and accelerating IP outsourcing position Arteris for rapid revenue growth and increased account stickiness amid AI and automotive adoption tailwinds. FlexGen and Magillem Packaging proliferation, validated by industry leaders, set the stage for margin expansion and rising contract values as industry complexity grows.
View narrative
US$16.00
FV
43.9% undervalued
intrinsic discount
19.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
GrafTech International
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Urbanization And Green Steel Will Drive Electrode Demand
Key Takeaways Strengthened market position and pricing strategies signal potential for substantial margin and earnings recovery, with an edge from vertical integration and raw material control. Regulatory tailwinds and decarbonization trends could unlock sustained demand growth, positioning the company as a vital supplier to Western steel and battery markets.
View narrative
US$2.00
FV
49.5% undervalued
intrinsic discount
28.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Value any company in seconds
Popular companies